Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide.
The mechanism of action of the topoisomerase II inhibitor etoposide (VP-16) was investigated in male mouse meiosis using the spermatid micronucleus (MN) test and two molecular cytogenetic approaches: (i) fluorescence in situ hybridization (FISH) with a mouse centromere specific minor satellite DNA probe; and (ii) immunolabelling of kinetochore proteins with CREST autoimmune serum. VP-16 caused significant increases in the frequencies of MN at all meiotic stages studied. VP-16 induced MN showed significantly elevated frequencies of centromeric hybridization signals compared to the controls. Similarly, after CREST immunostaining the majority of MN induced by the drug showed kinetochore signals when meiotic S phase and diplotene-diakinesis were treated. This would suggest that most induced MN were due to lagging of whole chromosomes. However, more than 80% of the small MN observed were signal-positive and a large pool of minute MN almost exclusively (92%) contained a kinetochore or centromere-DNA signal. This indicates that VP-16 causes chromosome fragmentation at centromeres. In addition, arrested first division (MI) anaphase figures with stretched bivalent(s) at the spindle equator were observed when diplotene-diakinesis and MI were targeted. Moreover, many small and medium size MN had two centromere or kinetochore signals at opposite sides, suggesting that inhibition of topo II at MI causes lagging of whole bivalents. Together, these results indicate that VP-16 acts by several genotoxic mechanisms at male meiosis: (i) fragmentation of centromeres possibly as a result of inhibition of the DNA strand religation reaction in a topoisomerase II mediated decatenation process of sister centromeres; and (ii) the induction of aneuploidy as a result of failures in separation of homologous chromosome arms possibly due to disturbances of chiasma resolution and decatenation processes during MI. Our results indirectly suggest that topoisomerase II plays an important role in male meiosis and its activity is needed at the metaphase-anaphase transition of both meiotic divisions for proper chromosome disjunction.
Kallio
M
M
Department of Medical Genetics, University of Turku, Finland.
Lähdetie
J
J
D000705:Anaphase / Q000187:drug effects; D000782:Aneuploidy; D000818:Animals; D017675:CREST Syndrome / Q000276:immunology; D002503:Centromere / Q000187:drug effects / Q000235:genetics*; D002875:Chromosomes / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects; D053938:DNA Fragmentation / Q000187:drug effects; D004276:DNA, Satellite; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology*; D019084:Fluorescent Antibody Technique, Indirect; D007106:Immune Sera; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D018386:Kinetochores / Q000187:drug effects / Q000276:immunology; D008297:Male; D008540:Meiosis / Q000187:drug effects*; D051379:Mice; D015162:Micronucleus Tests; D013087:Spermatids / Q000187:drug effects; D013997:Time Factors; D059005:Topoisomerase II Inhibitors
D004276:DNA, Satellite; D004791:Enzyme Inhibitors; D007106:Immune Sera; D059005:Topoisomerase II Inhibitors; D005047:Etoposide